RXCROSSROADS 3PL LLC — Vati Importer Profile
Pharmaceutical Importer · #15 buyer for Vati · $369.7K import value · 18 shipments · UNITED STATES · DGFT Verified
RXCROSSROADS 3PL LLC is the #15 importer of Vati from India with $369.7K in import value and 18 verified shipments. RXCROSSROADS 3PL LLC holds a 1.4% market share in Vati imports based in UNITED STATES. The company sources from 1 verified supplier across 6 formulations shipped to 1 country. Overall, RXCROSSROADS 3PL LLC imports 6 pharmaceutical products worth $6.4M across 5 therapeutic categories.
RXCROSSROADS 3PL LLC — Vati Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Vati to RXCROSSROADS 3PL LLC?
Verified from 18 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| STERISCIENCE SPECIALTIES PRIVATE LIMITED | $369.7K | 18 | 100.0% |
RXCROSSROADS 3PL LLC sources Vati from 1 verified Indian supplier based on 18 customs records. The primary supplier is STERISCIENCE SPECIALTIES PRIVATE LIMITED accounting for 100.0% of imports.
How Does RXCROSSROADS 3PL LLC Compare to Nearest Vati Importers?
Buyers ranked immediately above and below #15 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 13 | PLANET PHARMA SA | FRANCE | $491.4K | 12 | $40.9K |
| 14 | EMBASSY PHARMACEUTICAL AND CHEMICALS LIMITED | NIGERIA | $411.9K | 15 | $27.5K |
| 15 | RXCROSSROADS 3PL LLC ★ | UNITED STATES | $369.7K | 18 | $20.5K |
| 9 | AUROLOGISTICS LLC, (AUROBINDO PHARM | UNITED STATES | $300.0K | 6 | $50.0K |
| 19 | LLC SENTISS RUS | RUSSIA | $264.9K | 16 | $16.6K |
RXCROSSROADS 3PL LLC ranks #15 among 869 Vati importers from India. Average shipment value of $20.5K compared to the market average of $13.1K. The closest competitors by value are PLANET PHARMA SA and EMBASSY PHARMACEUTICAL AND CHEMICALS LIMITED.
Where Does RXCROSSROADS 3PL LLC Import Vati To?
Destination countries from 18 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $369.7K | 18 | 100.0% |
RXCROSSROADS 3PL LLC imports Vati to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $369.7K.
What Vati Formulations Does RXCROSSROADS 3PL LLC Import?
| Formulation | Value | Shipments |
|---|---|---|
| MIDAZOLAM INJECTION USP [5MG PER 5ML][1MG PER ML]PRESERVATIVE-FREE 10X5 ML SINGLE DOSE VIALS US SOMERSET(B/N:5100378) | $69.1K | 3 |
| MIDAZOLAM INJECTION USP[5MG PER 5ML][1MGPER ML]PRESERVATIVE-FREE 10X5 ML SINGLEDOSE VIALS US SOMERSET(B/N:5100379) | $68.3K | 3 |
| MIDAZOLAM INJECTION, USP [5MG PER 5ML] [1MG PER ML]PRESERVATIVE-FREE,10X5 ML SINGLE DOSE VIALS, US,SOMERSET(B/N:5100372) | $68.2K | 3 |
| MIDAZOLAM INJECTION USP[2MG PER 2ML][1MGPER ML]PRESERVATIVE-FREE 10X2 ML SINGLEDOSE VIALS US SOMERSET(B/N:5100383) | $55.9K | 3 |
| MIDAZOLAM INJECTION USP[2MG PER 2ML][1MGPER ML]PRESERVATIVE-FREE 10X2 ML SINGLEDOSE VIALS US SOMERSET(B/N:5100384) | $55.8K | 3 |
| MIDAZOLAM INJECTION, USP[2MG PER 2ML][1MG PER ML]PRESERVATIVE-FREE 10X2 ML SINGLE DOSE VIALS US SOMERSET(B/N:5100377) | $52.4K | 3 |
RXCROSSROADS 3PL LLC imports 6 distinct Vati formulations from India. The top formulation is MIDAZOLAM INJECTION USP [5MG PER 5ML][1MG PER ML]PRESERVATIV with 3 shipments worth $69.1K.
Regulatory Requirements: Importing Vati into United States
What RXCROSSROADS 3PL LLC and other importers must comply with to import Vati from India
Regulatory Authority
U.S. Food and Drug Administration (FDA)
Approval Process for Generic Vati
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
GMP Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
Import Licence & Documentation
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
Labeling & Packaging
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Vati from India and How Much Does RXCROSSROADS 3PL LLC Import?
India exported $11.4M worth of Vati through 5,725 shipments from 427 suppliers to 141 countries, serving 869 buyers globally. RXCROSSROADS 3PL LLC imports $369.7K of this total, accounting for 1.4% of India's Vati exports with 18 shipments from UNITED STATES. This is verified from 18 customs shipment records covering 6 distinct formulations.
What Is the Average Order Value for RXCROSSROADS 3PL LLC's Vati Imports?
RXCROSSROADS 3PL LLC's average Vati order value is $20.5K per consignment, based on 18 shipments totaling $369.7K. RXCROSSROADS 3PL LLC is based in UNITED STATES and ranks #15 among all Vati importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Vati to RXCROSSROADS 3PL LLC?
RXCROSSROADS 3PL LLC sources Vati from 1 verified Indian supplier: STERISCIENCE SPECIALTIES PRIVATE LIMITED ($369.7K, 100.0%). This is based on 18 customs records.
How Does RXCROSSROADS 3PL LLC Compare to Other Vati Importers?
RXCROSSROADS 3PL LLC ranks #15 among 869 Vati importers from India with a 1.4% market share. The top 3 importers are LIFESTAR PHARMA LLC ($2.7M), NORTHSTAR DISTRIBUTION CENTER 8912, ($1.1M), MSK PHARMALOGISTIC GMBH ($1.1M). RXCROSSROADS 3PL LLC processed 18 shipments from UNITED STATES.
About RXCROSSROADS 3PL LLC
RXCROSSROADS 3PL LLC imports 6 products worth $6.4M. Beyond Vati, top products include Tramadol, Ephedrine, Doxorubicin, Mitomycin, Pemetrexed. View the complete RXCROSSROADS 3PL LLC profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Vati — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Vati shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: RXCROSSROADS 3PL LLC matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as RXCROSSROADS 3PL LLC's capped import value divided by total capped export value for Vati across all Indian exporters.
- 5.Verified Records: This page is backed by 18 individual customs records matching RXCROSSROADS 3PL LLC importing Vati, covering 6 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 141+ countries, 869+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Vati Import Data for RXCROSSROADS 3PL LLC
Access order-level details, pricing data, supplier connections, and competitive analysis for RXCROSSROADS 3PL LLC's Vati imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
RXCROSSROADS 3PL LLC
Full Company Profile →
6 products · $6.4M total trade · 5 categories
RXCROSSROADS 3PL LLC × Vati
Verified from customs records
Company Overview
Top Products by RXCROSSROADS 3PL LLC
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for RXCROSSROADS 3PL LLC.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Vati. For current order-level data, contact TransData Nexus.